Results 121 to 130 of about 482,588 (310)

Impact of epicardial adipose tissue on myocardial function and structure in patients with severe aortic valve stenosis

ESC Heart Failure, EarlyView.
Epicardial adipose tissue (EAT) has been linked to adverse remodelling and outcomes in aortic valve stenosis (AS), yet mechanisms remain unclear. In 137 patients with severe AS undergoing CMR before TAVR, higher EAT (≥46.5 ml/m2) was associated with impaired left atrial (LA) reservoir strain, while ventricular morphology, function and tissue ...
Judith Gronwald, Torben Lange, Sören J. Backhaus, Bo E. Beuthner, Ruben Evertz, Miriam Puls, Johannes T. Kowallick, Karl Toischer, Gerd Hasenfuß, Andreas Schuster, Alexander Schulz   +10 more
wiley   +1 more source

Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD.

Journal of the American Society of Nephrology, 2017
Markus P. Schneider, U. Raff, C. Kopp, J. Scheppach, Sebastian Toncar, C. Wanner, G. Schlieper, Turgay Saritas, J. Floege, M. Schmid, A. Birukov, A. Dahlmann, P. Linz, R. Janka, M. Uder, R. Schmieder, J. Titze, K. Eckardt   +17 more
semanticscholar   +1 more source

Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study

ESC Heart Failure, EarlyView.
Abstract Aims Inflammation is postulated to be a key pathogenic mechanism in heart failure with preserved ejection fraction (HFpEF). Soluble urokinase plasminogen activator receptor (suPAR), a regulator of innate immune activity, is associated with incident heart failure; however, its role in HFpEF remains unclear.
Christina G. Hutten, Annika Tekumulla, Anis Ismail, Alexi Vasbinder, Theresa Farhat, Pennelope Kunkle, Sascha N. Goonewardena, Ahmed Abdel‐Latif, Bertram Pitt, Salim S. Hayek   +9 more
wiley   +1 more source

Correlation between left ventricular hypertrophy and diastolic dysfunction in arterial hypertension

Терапевтический архив, 2003
Aim. To evaluate relationships between arterial pressure (AP), myocardial mass of the left ventricle (LVMM) and left ventricular diastolic function (LVDF) in patients with hypertension stage I and II. Material and methods. 89 hypertensive patients and 30
Z К Trushinsky, Yu V Dovgalyuk, О Yu Skritskaya   +2 more
doaj  

Finerenone in diabetic chronic kidney disease—Real‐world insights including patients with HFpEF or HFmrEF

ESC Heart Failure, EarlyView.
Abstract Purpose Finerenone, a highly selective non‐steroidal mineralocorticoid receptor antagonist, was approved for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (diabetic kidney disease, DKD). Finerenone reduced the composite endpoint of heart failure events and cardiovascular death in patients with heart ...
Kristian Hellenkamp, Sophia Kaebe, Miroslava Valentova, Stephan von Haehling, Fani Delistefani, Katja Gollisch, Dirk Raddatz, Ann‐Kathrin Schäfer, Michael J. Koziolek, Manuel Wallbach   +9 more
wiley   +1 more source

Circulating oxylipins predict mortality in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
A targeted LC–MS lipidomics approach identified arterial 15‐keto PGF2a as associated with 5‐year mortality in 90 patients with HFpEF. Abstract Aims Heart failure with preserved ejection fraction (HFpEF) poses significant diagnostic, prognostic and therapeutic challenges, with high morbidity and mortality rates.
Vaishnavi Aradhyula, Sareeta Manandhar, Alborz Sherafati, Alex Kloster, Anas Fares, Prabhatchandra Dube, Pamela S. Brewster, George V. Moukarbel, Krishna Rao Maddipati, Steven T. Haller, David J. Kennedy, Rajesh Gupta, Samer J. Khouri   +12 more
wiley   +1 more source

Assessing cardiovascular benefits of intensive blood pressure lowering in high‐risk undiagnosed HFpEF patients

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is often underdiagnosed. This study evaluates the HFpEF‐ABA score's ability to identify high‐risk, undiagnosed HFpEF subgroups with elevated cardiovascular event rates and assesses the impact of intensive blood pressure control in these populations.
Xinru Liu, Zhiyan Wang, Chang Hua, Yanfang Wu, Yangyang Tang, Yuling Xiong, Jingwei Liu, Jiaqi Zhang, Qiang Lv, Chao Jiang, Jianzeng Dong, Xin Du   +11 more
wiley   +1 more source

Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.

Circulation Research, 2016
Lin Zhao, Guangming Cheng, R. Jin, M. Afzal, A. Samanta, Y. Xuan, M. Girgis, Harold K Elias, Yanqing Zhu, Arash Davani, Yanjuan Yang, Xingdong Chen, Sheng Ye, O. Wang, Lei Chen, Jeryl Hauptman, Robert J. Vincent, B. Dawn   +17 more
semanticscholar   +1 more source

Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR‐CM

ESC Heart Failure, EarlyView.
Abstract Aims Patients with transthyretin amyloid cardiomyopathy (ATTR‐CM) often experience delayed diagnosis, which may detrimentally impact clinical outcomes. This study aimed to assess the frequency of use of planar scintigraphy with and without single‐photon emission computed tomography (SPECT) in patients with hypertrophic cardiomyopathy (HCM ...
Pablo Garcia‐Pavia, Francisco Javier Haro del Moral, Francesco Cappelli, Nicolas Piriou, Roberto Barriales‐Villa, Carmen Munteanu, Catherine Bahus, Denis Keohane, Pablo Mallaina, Emmanuel Itti, Thibaud Damy, Perry Elliott   +11 more
wiley   +1 more source

Use of artificial intelligence for detecting left ventricular dysfunction and predicting incident heart failure risk

ESC Heart Failure, EarlyView.
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek, Monika Przewlocka‐Kosmala, Wojciech Kosmala, Thomas H. Marwick   +3 more
wiley   +1 more source